Loading inventors, assignments & file history…
Abstract
The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine.
Claims (3)
1. A method of treating colitis comprising administering to a patient in need thereof an effective amount of a composition comprising lactic acid bacteria Lactobacillus farciminis.
2. The method of claim 1 wherein said colitis results from a pathology selected from the groups consisting of Crohn's disease, hemorrhagic rectocolitis, and irritable bowel syndrome.
3. The method of claim 1 wherein the composition is in the form of a foodstuff or a dietary supplement.
Assignments (2)
CHANGE OF NAME
Recorded Jun 15, 2021
From: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA)
To: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Reel/Frame 056592/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 23, 2005
From: FIORAMONTI, JEAN; BUENO, LIONEL; THEODOROU, VASSILIA; LAMINE, FLORENCE
To: INSTITUT NATIONAL DE LA RESCHERCHE AGRONOMIQUE (INRA)
Reel/Frame 016268/0702 →
Priority Claims (1)
FR 02 03891
· Mar 28, 2002
· national
Continuity (1)